These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37321320)

  • 1. Negative regulatory NLRs mitigate inflammation via NF-κB pathway signaling in inflammatory bowel disease.
    Morrison HA; Trusiano B; Rowe AJ; Allen IC
    Biomed J; 2023 Oct; 46(5):100616. PubMed ID: 37321320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on negatively regulated NLRs in inflammation and cancer.
    Wang J; He W; Li C; Ma Y; Liu M; Ye J; Sun L; Su J; Zhou L
    Int Immunopharmacol; 2024 Jul; 136():112347. PubMed ID: 38820966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.
    McDaniel DK; Eden K; Ringel VM; Allen IC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2265-79. PubMed ID: 27508514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis.
    Kim HW; Kwon YJ; Park BW; Song JJ; Park YB; Park MC
    Clin Exp Rheumatol; 2017; 35(4):630-637. PubMed ID: 28240593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
    Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of NLRX1 by NX-13 Alleviates Inflammatory Bowel Disease through Immunometabolic Mechanisms in CD4
    Leber A; Hontecillas R; Zoccoli-Rodriguez V; Bienert C; Chauhan J; Bassaganya-Riera J
    J Immunol; 2019 Dec; 203(12):3407-3415. PubMed ID: 31694910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF Blockade Attenuates DSS-Induced Chronic Colitis
    Zhang Y; Tao M; Chen C; Zhao X; Feng Q; Chen G; Fu Y
    Front Immunol; 2022; 13():783254. PubMed ID: 35320937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
    Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
    Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.
    Allen IC; Moore CB; Schneider M; Lei Y; Davis BK; Scull MA; Gris D; Roney KE; Zimmermann AG; Bowzard JB; Ranjan P; Monroe KM; Pickles RJ; Sambhara S; Ting JP
    Immunity; 2011 Jun; 34(6):854-65. PubMed ID: 21703540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.
    Allen IC; Wilson JE; Schneider M; Lich JD; Roberts RA; Arthur JC; Woodford RM; Davis BK; Uronis JM; Herfarth HH; Jobin C; Rogers AB; Ting JP
    Immunity; 2012 May; 36(5):742-54. PubMed ID: 22503542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease.
    Mukherjee T; Kumar N; Chawla M; Philpott DJ; Basak S
    Sci Signal; 2024 Jan; 17(818):eadh1641. PubMed ID: 38194476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP12 in innate immunity and inflammation.
    Tuladhar S; Kanneganti TD
    Mol Aspects Med; 2020 Dec; 76():100887. PubMed ID: 32838963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.
    Coutermarsh-Ott S; Eden K; Allen IC
    J Gen Virol; 2016 Apr; 97(4):825-838. PubMed ID: 26763980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linagliptin mitigates experimental inflammatory bowel disease in rats by targeting inflammatory and redox signaling.
    Arab HH; Eid AH; Mahmoud AM; Senousy MA
    Life Sci; 2021 May; 273():119295. PubMed ID: 33667522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice.
    Yuan SN; Wang MX; Han JL; Feng CY; Wang M; Wang M; Sun JY; Li NY; Simal-Gandara J; Liu C
    Phytomedicine; 2023 Apr; 112():154702. PubMed ID: 36764096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.
    Fekete T; Bencze D; Szabo A; Csoma E; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():2314. PubMed ID: 30344524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging significance of NLRs in inflammatory bowel disease.
    Davis BK; Philipson C; Hontecillas R; Eden K; Bassaganya-Riera J; Allen IC
    Inflamm Bowel Dis; 2014 Dec; 20(12):2412-32. PubMed ID: 25153506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the noninflammasome NLRs function in the innate immune system.
    Ting JP; Duncan JA; Lei Y
    Science; 2010 Jan; 327(5963):286-90. PubMed ID: 20075243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation.
    Dou W; Zhang J; Ren G; Ding L; Sun A; Deng C; Wu X; Wei X; Mani S; Wang Z
    Int Immunopharmacol; 2014 Nov; 23(1):170-8. PubMed ID: 25194678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis.
    Allen IC
    Front Immunol; 2014; 5():169. PubMed ID: 24795716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.